Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Intramyocardial injected human umbilical cord-derived mesenchymal stem cells (HucMSCs) contribute to the recovery of cardiac function and the migration of CD4+ T cells into the infarcted heart via CCL5/CCR5 signaling

Fig. 6

HucMSCs promoted CD4+ T cells migration into the injured heart via high levels of CCL5 post MI. A Statistical results of the T cells associated cytokines and chemokines in the heart between MI-N.S and MI-HucMSC groups on day 7. B The radar plots showed differences in cytokines between MI-N.S and MI-HucMSC groups on day 7. C The protein levels of CCL2 and CCL5 in heart tissues of two groups on day 7. *p < 0.05 and ***p < 0.001 versus MI-N.S group. D In vitro, statistical results of migrated CD4+ T cells number via different treatments. ##p < 0.01 versus Control group, &&&p < 0.001 versus MI-N.S group, *p < 0.05 versus MI-HucMSC group

Back to article page